Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026

Rhea-AI Summary

Genvor (OTCQB:GNVR) announced that CEO Chad Pawlak will present a corporate update at the National Investment Banking Association's 152nd Investment Conference in Fort Lauderdale on March 12, 2026.

The presentation will cover the company's AI-accelerated peptide platform, recent milestones, technology advancements and upcoming growth initiatives; management will be available for one-on-one investor meetings.

CEO Chad Pawlak to deliver corporate update on AI-accelerated peptide platform and strategic growth initiatives

WOODLAND, CA / ACCESS Newswire / March 5, 2026 / Genvor, Inc. (OTCQB:GNVR) ("Genvor" or the "Company") is pleased to announce that Chief Executive Officer Chad Pawlak will be presenting at the National Investment Banking Association's (NIBA) 152nd Investment Conference in Fort Lauderdale, Florida on March 12, 2026.

The presentation will include a corporate update highlighting the Company's recent milestones, technology platform advancements and upcoming growth initiatives. Attendees and investors are encouraged to schedule one-on-one meetings with management during the conference.

NIBA's 152nd Investment Conference will be held March 11-12, 2026 at the Westin Fort Lauderdale Beach Resort. For more information or to register, please visit: https://nibas-152nd-investment-conference.events.accessnewswire.com/

About Genvor

Genvor, Inc. (OTCQB:GNVR) is a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health. Genvor's proprietary BioCypher platform designs peptides that enhance crop performance, reduce chemical inputs, and support human recovery and wellness. Through strategic partnerships and a dual-market commercialization model, Genvor is advancing peptide science from field to finish line. For more information, visit www.genvor.com.

About National Investment Banking Association

The National Investment Banking Association (NIBA) is a non-profit organization that has been serving the micro-cap and small-cap investment community for over 40 years. NIBA's 152nd Investment Conference website is available here: https://nibas-152nd-investment-conference.events.accessnewswire.com/

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied. Genvor undertakes no obligation to update forward-looking statements except as required by applicable law.

For more information contact:

Investor Relations
Genvor Incorporated
Marketing@genvor.com
www.genvor.com

Media
Carly Scaduto
carly@carlyscadutoconsulting.com

SOURCE: Genvor, Inc.

View the original press release on ACCESS Newswire

FAQ

When is Genvor (GNVR) presenting at NIBA's 152nd Investment Conference?

Genvor's CEO will present on March 12, 2026 at the NIBA conference. According to the company, the presentation is part of the conference running March 11-12, 2026 at the Westin Fort Lauderdale Beach Resort, with management available for one-on-one meetings.

What will Chad Pawlak discuss in the Genvor (GNVR) presentation on March 12, 2026?

He will deliver a corporate update focused on the AI-accelerated peptide platform and growth plans. According to the company, the talk will highlight recent milestones, technology platform advancements and upcoming strategic initiatives relevant to investors.

How can investors meet Genvor (GNVR) management at the March 2026 NIBA conference?

Investors are encouraged to schedule one-on-one meetings with Genvor management during the conference. According to the company, attendees should register for NIBA and arrange meetings directly with the investor relations contacts or via conference scheduling tools.

Where and when is NIBA's 152nd Investment Conference taking place for GNVR attendees?

NIBA's 152nd Investment Conference is March 11-12, 2026 at the Westin Fort Lauderdale Beach Resort. According to the company, Genvor's presentation occurs on March 12, 2026, and registration details are available through the conference website.

Will Genvor (GNVR) provide technical or commercial detail in its March 12, 2026 presentation?

The presentation will cover technology advancements and recent milestones but specifics are not enumerated in the notice. According to the company, the update will outline the AI-accelerated peptide platform and upcoming growth initiatives for investor context.